Copyright Reports & Markets. All rights reserved.

Global and United States Oncology Based In-vivo CRO Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Oncology Based In-vivo CRO Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 Blood cancer
    • 1.2.3 Solid tumors
    • 1.2.4 Other
  • 1.3 Market by Application
    • 1.3.1 Global Oncology Based In-vivo CRO Market Share by Application: 2020 VS 2026
    • 1.3.2 Hospitals
    • 1.3.3 Rehabilitation Centers
    • 1.3.4 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Oncology Based In-vivo CRO Market Perspective (2015-2026)
  • 2.2 Global Oncology Based In-vivo CRO Growth Trends by Regions
    • 2.2.1 Oncology Based In-vivo CRO Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Oncology Based In-vivo CRO Historic Market Share by Regions (2015-2020)
    • 2.2.3 Oncology Based In-vivo CRO Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Oncology Based In-vivo CRO Players by Market Size
    • 3.1.1 Global Top Oncology Based In-vivo CRO Players by Revenue (2015-2020)
    • 3.1.2 Global Oncology Based In-vivo CRO Revenue Market Share by Players (2015-2020)
  • 3.2 Global Oncology Based In-vivo CRO Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Oncology Based In-vivo CRO Revenue
  • 3.4 Global Oncology Based In-vivo CRO Market Concentration Ratio
    • 3.4.1 Global Oncology Based In-vivo CRO Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Oncology Based In-vivo CRO Revenue in 2019
  • 3.5 Key Players Oncology Based In-vivo CRO Area Served
  • 3.6 Key Players Oncology Based In-vivo CRO Product Solution and Service
  • 3.7 Date of Enter into Oncology Based In-vivo CRO Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Oncology Based In-vivo CRO Breakdown Data by Type (2015-2026)

  • 4.1 Global Oncology Based In-vivo CRO Historic Market Size by Type (2015-2020)
  • 4.2 Global Oncology Based In-vivo CRO Forecasted Market Size by Type (2021-2026)

5 Oncology Based In-vivo CRO Breakdown Data by Application (2015-2026)

  • 5.1 Global Oncology Based In-vivo CRO Historic Market Size by Application (2015-2020)
  • 5.2 Global Oncology Based In-vivo CRO Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Oncology Based In-vivo CRO Market Size (2015-2026)
  • 6.2 North America Oncology Based In-vivo CRO Market Size by Type (2015-2020)
  • 6.3 North America Oncology Based In-vivo CRO Market Size by Application (2015-2020)
  • 6.4 North America Oncology Based In-vivo CRO Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Oncology Based In-vivo CRO Market Size (2015-2026)
  • 7.2 Europe Oncology Based In-vivo CRO Market Size by Type (2015-2020)
  • 7.3 Europe Oncology Based In-vivo CRO Market Size by Application (2015-2020)
  • 7.4 Europe Oncology Based In-vivo CRO Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Oncology Based In-vivo CRO Market Size (2015-2026)
  • 8.2 China Oncology Based In-vivo CRO Market Size by Type (2015-2020)
  • 8.3 China Oncology Based In-vivo CRO Market Size by Application (2015-2020)
  • 8.4 China Oncology Based In-vivo CRO Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Oncology Based In-vivo CRO Market Size (2015-2026)
  • 9.2 Japan Oncology Based In-vivo CRO Market Size by Type (2015-2020)
  • 9.3 Japan Oncology Based In-vivo CRO Market Size by Application (2015-2020)
  • 9.4 Japan Oncology Based In-vivo CRO Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Oncology Based In-vivo CRO Market Size (2015-2026)
  • 10.2 Southeast Asia Oncology Based In-vivo CRO Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Oncology Based In-vivo CRO Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Oncology Based In-vivo CRO Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

  • 11.1 Crown Bioscience
    • 11.1.1 Crown Bioscience Company Details
    • 11.1.2 Crown Bioscience Business Overview
    • 11.1.3 Crown Bioscience Oncology Based In-vivo CRO Introduction
    • 11.1.4 Crown Bioscience Revenue in Oncology Based In-vivo CRO Business (2015-2020))
    • 11.1.5 Crown Bioscience Recent Development
  • 11.2 Charles River Laboratory
    • 11.2.1 Charles River Laboratory Company Details
    • 11.2.2 Charles River Laboratory Business Overview
    • 11.2.3 Charles River Laboratory Oncology Based In-vivo CRO Introduction
    • 11.2.4 Charles River Laboratory Revenue in Oncology Based In-vivo CRO Business (2015-2020)
    • 11.2.5 Charles River Laboratory Recent Development
  • 11.3 ICON Plc.
    • 11.3.1 ICON Plc. Company Details
    • 11.3.2 ICON Plc. Business Overview
    • 11.3.3 ICON Plc. Oncology Based In-vivo CRO Introduction
    • 11.3.4 ICON Plc. Revenue in Oncology Based In-vivo CRO Business (2015-2020)
    • 11.3.5 ICON Plc. Recent Development
  • 11.4 Eurofins Scientific
    • 11.4.1 Eurofins Scientific Company Details
    • 11.4.2 Eurofins Scientific Business Overview
    • 11.4.3 Eurofins Scientific Oncology Based In-vivo CRO Introduction
    • 11.4.4 Eurofins Scientific Revenue in Oncology Based In-vivo CRO Business (2015-2020)
    • 11.4.5 Eurofins Scientific Recent Development
  • 11.5 Taconic Biosciences
    • 11.5.1 Taconic Biosciences Company Details
    • 11.5.2 Taconic Biosciences Business Overview
    • 11.5.3 Taconic Biosciences Oncology Based In-vivo CRO Introduction
    • 11.5.4 Taconic Biosciences Revenue in Oncology Based In-vivo CRO Business (2015-2020)
    • 11.5.5 Taconic Biosciences Recent Development
  • 11.6 Covance
    • 11.6.1 Covance Company Details
    • 11.6.2 Covance Business Overview
    • 11.6.3 Covance Oncology Based In-vivo CRO Introduction
    • 11.6.4 Covance Revenue in Oncology Based In-vivo CRO Business (2015-2020)
    • 11.6.5 Covance Recent Development
  • 11.7 EVOTEC
    • 11.7.1 EVOTEC Company Details
    • 11.7.2 EVOTEC Business Overview
    • 11.7.3 EVOTEC Oncology Based In-vivo CRO Introduction
    • 11.7.4 EVOTEC Revenue in Oncology Based In-vivo CRO Business (2015-2020)
    • 11.7.5 EVOTEC Recent Development
  • 11.8 The Jackson Laboratory
    • 11.8.1 The Jackson Laboratory Company Details
    • 11.8.2 The Jackson Laboratory Business Overview
    • 11.8.3 The Jackson Laboratory Oncology Based In-vivo CRO Introduction
    • 11.8.4 The Jackson Laboratory Revenue in Oncology Based In-vivo CRO Business (2015-2020)
    • 11.8.5 The Jackson Laboratory Recent Development
  • 11.9 Wuxi AppTec.
    • 11.9.1 Wuxi AppTec. Company Details
    • 11.9.2 Wuxi AppTec. Business Overview
    • 11.9.3 Wuxi AppTec. Oncology Based In-vivo CRO Introduction
    • 11.9.4 Wuxi AppTec. Revenue in Oncology Based In-vivo CRO Business (2015-2020)
    • 11.9.5 Wuxi AppTec. Recent Development
  • 11.10 MI Bioresearch, Inc.
    • 11.10.1 MI Bioresearch, Inc. Company Details
    • 11.10.2 MI Bioresearch, Inc. Business Overview
    • 11.10.3 MI Bioresearch, Inc. Oncology Based In-vivo CRO Introduction
    • 11.10.4 MI Bioresearch, Inc. Revenue in Oncology Based In-vivo CRO Business (2015-2020)
    • 11.10.5 MI Bioresearch, Inc. Recent Development
  • 11.11 Living Tumor Laboratory
    • 10.11.1 Living Tumor Laboratory Company Details
    • 10.11.2 Living Tumor Laboratory Business Overview
    • 10.11.3 Living Tumor Laboratory Oncology Based In-vivo CRO Introduction
    • 10.11.4 Living Tumor Laboratory Revenue in Oncology Based In-vivo CRO Business (2015-2020)
    • 10.11.5 Living Tumor Laboratory Recent Development
  • 11.12 Champion Oncology, Inc.
    • 10.12.1 Champion Oncology, Inc. Company Details
    • 10.12.2 Champion Oncology, Inc. Business Overview
    • 10.12.3 Champion Oncology, Inc. Oncology Based In-vivo CRO Introduction
    • 10.12.4 Champion Oncology, Inc. Revenue in Oncology Based In-vivo CRO Business (2015-2020)
    • 10.12.5 Champion Oncology, Inc. Recent Development
  • 11.13 Xentech
    • 10.13.1 Xentech Company Details
    • 10.13.2 Xentech Business Overview
    • 10.13.3 Xentech Oncology Based In-vivo CRO Introduction
    • 10.13.4 Xentech Revenue in Oncology Based In-vivo CRO Business (2015-2020)
    • 10.13.5 Xentech Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Oncology Based In-vivo CRO Scope and Market Size
    Oncology Based In-vivo CRO market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Oncology Based In-vivo CRO market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Blood cancer
    Solid tumors
    Other

    Market segment by Application, split into
    Hospitals
    Rehabilitation Centers
    Others

    Based on regional and country-level analysis, the Oncology Based In-vivo CRO market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global Oncology Based In-vivo CRO market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Crown Bioscience
    Charles River Laboratory
    ICON Plc.
    Eurofins Scientific
    Taconic Biosciences
    Covance
    EVOTEC
    The Jackson Laboratory
    Wuxi AppTec.
    MI Bioresearch, Inc.
    Living Tumor Laboratory
    Champion Oncology, Inc.
    Xentech

    Buy now